We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.74B
AUM Growth
+$18.9M
Cap. Flow
-$61.5M
Cap. Flow %
-3.53%
Top 10 Hldgs %
23.9%
Holding
276
New
11
Increased
44
Reduced
193
Closed
16

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$13M
2
DOCS icon
Doximity
DOCS
+$10.2M
3
LOB icon
Live Oak Bancshares
LOB
+$7.32M
4
RXO icon
RXO
RXO
+$7.31M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.78M

Top Sells

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$24.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$12.4M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$12.3M
4
XPO icon
XPO
XPO
+$7.84M
5
RXT icon
Rackspace Technology
RXT
+$5.42M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Healthcare 26.13%
3 Industrials 15.45%
4 Consumer Discretionary 11.41%
5 Communication Services 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UMPQ
76
DELISTED
Umpqua Holdings Corp
UMPQ
$5.44M 0.31%
304,860
-7,083
-2% -$133K
OR icon
77
OR Royalties Inc
OR
$6.29B
$5.37M 0.31%
444,865
-8,691
-2% -$101K
MSM icon
78
MSC Industrial Direct
MSM
$6.84B
$5.37M 0.31%
65,708
-46
-0.1% -$3.75K
SNBR
79
DELISTED
Sleep Number
SNBR
$5.37M 0.31%
206,554
-9,439
-4% -$287K
GXO icon
80
GXO Logistics
GXO
$5.42B
$5.28M 0.3%
123,707
-195
-0.2% -$7.82K
CLNE icon
81
Clean Energy Fuels
CLNE
$346M
$5.23M 0.3%
1,006,063
+152,693
+18% +$938K
TRAK icon
82
ReposiTrak
TRAK
$155M
$5.2M 0.3%
1,050,641
-32,886
-3% -$167K
HURN icon
83
Huron Consulting
HURN
$2.44B
$5.04M 0.29%
69,437
-2,058
-3% -$151K
UFPT icon
84
UFP Technologies
UFPT
$2.47B
$4.99M 0.29%
42,341
-23,876
-36% -$2.55M
DEN
85
DELISTED
Denbury Inc.
DEN
$4.98M 0.29%
57,242
-1,802
-3% -$164K
MODV
86
DELISTED
ModivCare
MODV
$4.97M 0.29%
55,434
+30,918
+126% +$2.76M
INSM icon
87
Insmed
INSM
$29B
$4.95M 0.28%
247,589
-1,341
-0.5% -$25.9K
MATV icon
88
Mativ Holdings
MATV
$692M
$4.92M 0.28%
235,526
+14,161
+6% +$307K
ERII icon
89
Energy Recovery
ERII
$412M
$4.63M 0.27%
225,771
-8,708
-4% -$191K
OPRX icon
90
OptimizeRx
OPRX
$127M
$4.57M 0.26%
271,822
+73,728
+37% +$1.27M
HRMY icon
91
Harmony Biosciences
HRMY
$2.27B
$4.54M 0.26%
82,318
-23,809
-22% -$1.31M
STRL icon
92
Sterling Infrastructure
STRL
$16.5B
$4.53M 0.26%
138,105
-51,491
-27% -$1.51M
RYTM icon
93
Rhythm Pharmaceuticals
RYTM
$7.9B
$4.46M 0.26%
153,202
-17,155
-10% -$441K
POWI icon
94
Power Integrations
POWI
$3.49B
$4.34M 0.25%
60,479
-969
-2% -$69.2K
LUNA
95
DELISTED
Luna Innovations Incorporated
LUNA
$4.33M 0.25%
492,798
-20,525
-4% -$130K
FIVE icon
96
Five Below
FIVE
$13.1B
$4.3M 0.25%
24,334
-1,518
-6% -$239K
HAE icon
97
Haemonetics
HAE
$3.93B
$4.14M 0.24%
52,626
-29,997
-36% -$2.41M
VPG icon
98
Vishay Precision Group
VPG
$884M
$4.07M 0.23%
105,179
-4,318
-4% -$157K
ELF icon
99
e.l.f. Beauty
ELF
$5.66B
$4.05M 0.23%
73,181
-3,066
-4% -$150K
CRAI icon
100
CRA International
CRAI
$1.09B
$4.04M 0.23%
32,987
-1,330
-4% -$147K
2 3
4
5 6

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Rice Hall James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Rice Hall James & Associates held 276 positions worth $1.74B, up 1.1% from $1.72B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $61.5M in Q4 2022, closing 16 positions and reducing 193 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in OmniAb worth $8.94M.

  • Rice Hall James & Associates's largest Q4 2022 buy was OmniAb: 2,483,766 shares worth $8.94M.
  • Rice Hall James & Associates added most to Doximity in Q4 2022, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $12.3M.
  • Rice Hall James & Associates fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $24.3M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.74B portfolio in Q4 2022.
  • Rice Hall James & Associates opened 11 new positions and closed 16 in Q4 2022.
  • Rice Hall James & Associates's portfolio value rose 1.1% quarter-over-quarter to $1.74B.

Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.